Literature DB >> 12719858

Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age.

Jan R Ortlepp1, Katharina Vesper, Vera Mevissen, Fabian Schmitz, Uwe Janssens, Andreas Franke, Peter Hanrath, Christian Weber, Klaus Zerres, Rainer Hoffmann.   

Abstract

Inflammation is associated with atherosclerosis of coronary arteries. Chemokines have an important role in inflammation. The CCR2 chemokine receptor mediates leukocyte chemoattraction, which is involved in the pathogenesis of coronary heart disease. We prospectively studied 1960 consecutive patients aged under 65 years and referred for a first-time left ventricular catheter. Left heart catheters were analyzed by two independent cardiologists for the presence of myocardial infarction (regional wall motion abnormality) and moderate or severely reduced left ventricular function on cineventriculography and presence of coronary atherosclerosis on angiography. Genotyping for CCR2 V64I polymorphism was performed. The presence of the rare allele of the CCR2 gene was significantly associated with a higher prevalence of myocardial infarction on cinventriculography (32.0% vs. 24.2%, moderately or severely reduced left ventricular function (14.0% vs. 9.5%) and NYHA class III or IV (16.7% vs. 12.2%). The association of the CCR2 genotype with heart failure was not independent of the presence of myocardial infarction in multivariate analysis. There was no association of the CCR2 genotype with coronary atherosclerosis. The CCR2 genotype seems to predispose patients for myocardial infarction before the age of 65 years. The higher prevalence of heart failure in gene carriers with the rare alle might be a consequence of myocardial infarction. If the CCR2 genotype is associated with higher mortality in the general population must be investigated in further studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719858     DOI: 10.1007/s00109-003-0435-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  11 in total

1.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

Authors:  K J Livak
Journal:  Genet Anal       Date:  1999-02

Review 2.  Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules.

Authors:  Christian Weber
Journal:  J Mol Med (Berl)       Date:  2002-11-13       Impact factor: 4.599

3.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  Freely associating.

Authors: 
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 5.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.

Authors:  P González; R Alvarez; A Batalla; J R Reguero; V Alvarez; A Astudillo; G I Cubero; A Cortina; E Coto
Journal:  Genes Immun       Date:  2001-06       Impact factor: 2.676

Review 7.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

8.  Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification.

Authors:  Ana M Valdes; Megan L Wolfe; Eamonn J O'Brien; Nigel K Spurr; Warren Gefter; Andrew Rut; Pieter H E Groot; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

9.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

10.  Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

Authors:  R P van Rij; A M de Roda Husman; M Brouwer; J Goudsmit; R A Coutinho; H Schuitemaker
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  19 in total

1.  Freely associating with chemokine receptor 2 polymorphisms and atherosclerosis.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-06       Impact factor: 4.599

2.  Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

Authors:  Diederik F van Wijk; Sander I van Leuven; Manjinder S Sandhu; Michael W Tanck; Barbara A Hutten; Nicholas J Wareham; John J P Kastelein; Erik S G Stroes; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

3.  Relationship of five inflammatory gene polymorphisms with morbidity and mortality in 533 patients admitted to an ICU.

Authors:  Jan R Ortlepp; Jürgen Graf; Katharina Vesper; Fabian Schmitz; Vera Mevissen; Sebastian Sucigan; Alexander Kersten; Christian Weber; Uwe Janssens
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

4.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

Review 5.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

6.  CCR2 and coronary artery disease: a woscops substudy.

Authors:  David J Dow; Alex D McMahon; Ian C Gray; Chris J Packard; Pieter He Groot
Journal:  BMC Res Notes       Date:  2010-02-02

7.  Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.

Authors:  Noah Saederup; Liana Chan; Sergio A Lira; Israel F Charo
Journal:  Circulation       Date:  2007-12-28       Impact factor: 29.690

8.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

Review 9.  An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion.

Authors:  Jana Barlic; Philip M Murphy
Journal:  Trends Cardiovasc Med       Date:  2007-11       Impact factor: 6.677

10.  Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.

Authors:  Paul A Nyquist; Cherie A Winkler; Louise M McKenzie; Lisa R Yanek; Lewis C Becker; Diane M Becker
Journal:  Cerebrovasc Dis       Date:  2009-06-05       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.